Study to categorize lung fibrosis types at a clinic
Part of Lungs & breathing clinical trials.
This study enrolls people who have interstitial lung disease and are seen at the Edinburgh lung fibrosis clinic. It aims to sort different underlying “types” of lung fibrosis so doctors can better understand and potentially guide care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have interstitial lung disease (lung scarring/changes).
- You attend the Edinburgh lung fibrosis service (the clinic in Edinburgh).
- Your clinician considers you suitable to join the study.
- You can follow the study requirements as asked.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study is looking at people with Idiopathic Pulmonary Fibrosis (IPF), a type of lung scarring. Researchers will use medical records to see if they can better predict how the disease will progress over time.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
This study follows people who are being seen for lung scarring (also called ILD) and compares them with family members without lung scarring. It helps researchers better understand how this condition changes over time and what to look for in the future.
This study is for people with a specific type of lung scarring (not IPF) to understand how the disease progresses. Researchers will collect detailed health information, imaging, and blood samples to learn more about the condition.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.